Search

Your search keyword '"Marmol, V. D."' showing total 4 results
Start Over Author "Marmol, V. D."
4 results on '"Marmol, V. D."'

1. Diagnosis and treatment of Kaposi's sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC)

Author

Lebbe, C., Garbe, C., Stratigos, A. J., Harwood, C., Peris, Ketty, Marmol, V. D., Malvehy, J., Zalaudek, Iri, Hoeller, C., Dummer, R., Forsea, A. M., Kandolf-Sekulovic, L., Olah, J., Arenberger, P., Bylaite-Bucinskiene, M., Vieira, R., Middleton, M., Levy, A., Eggermont, A. M., Battistella, M., Spano, J. P., Grob, J. J., Pages, C., Peris K. (ORCID:0000-0002-5237-0463), Zalaudek I., Lebbe, C., Garbe, C., Stratigos, A. J., Harwood, C., Peris, Ketty, Marmol, V. D., Malvehy, J., Zalaudek, Iri, Hoeller, C., Dummer, R., Forsea, A. M., Kandolf-Sekulovic, L., Olah, J., Arenberger, P., Bylaite-Bucinskiene, M., Vieira, R., Middleton, M., Levy, A., Eggermont, A. M., Battistella, M., Spano, J. P., Grob, J. J., Pages, C., Peris K. (ORCID:0000-0002-5237-0463), and Zalaudek I.

Abstract

Kaposi's sarcoma (KS)is a multifocal neoplasm of lymphatic endothelium-derived cells infected with human herpesvirus 8. Four clinical subtypes are distinguished: the classic, the endemic, the epidemic subtype in HIV positive patients and the iatrogenic subtype. The diagnosis is primarily based on clinical features and confirmation by histology with immunohistochemistry. Cutaneous distribution and severity, mucosal, nodal and visceral involvement depend on the type of KS with in general indolent behaviour and chronic evolution in the classic subtype and the more severe forms in iatrogenic or epidemic subtypes. Management should aim at achieving disease control. For localised lesions, several local therapies have been developed without randomised trial comparisons. Radiotherapy, intralesional chemotherapies and electrochemotherapy have high response rates. Topical treatments—imiquimod or topical 9-cis-retinoid acid—can also be used. Systemic treatments are reserved for locally aggressive extensive and disseminated KS: the recommended first-line agents are pegylated liposomal doxorubicin (PLD)and paclitaxel. In CKS, PLD or low-dose interferon-alfa are the recommended first-line agents in younger patients. In AIDS-related KS, combination antiretroviral therapy is the first treatment option; specific systemic treatment is needed only in case of extensive disease and in the prevention and treatment of immune reconstitution inflammatory syndrome. In post-transplant KS, tapering down immunosuppressive therapy and switching to mammalian target of rapamycin (m-TOR)inhibitors are used. Follow-up schedules for patients with KS disease depend on aggressiveness of the disease.

Published
2019

2. Clinical characteristics of low and high BMI Hidradenitis suppurativa patients

Author

Abdel-Wahab, H., Zouboulis, C., El-Domyati, M., Guillem, P., Benhadou, F., Marmol, V. D., Jemec, G. B. E., Saunte, D., Riis, P. Theut, Karagiannidis, I., Doss, N., Kottb, H. Riad, Lapins, J., Emtestam, L., Mathusiak, L., Massa, A. F., Hamzavi, I., Nicholson, C., Dolenc-Voljc, M., Kim, K. Han, Ohn, J., Szepietowski, J., Beksac, B., Gurer, M. Ali, Dessinioti, C., Antoniou, C., Durienc, P., and Mokos, Z. Bukvic

Published
2017

4. The status of dermoscopy in Germany - results of the cross-sectional Pan-Euro-Dermoscopy Study.

Author

Blum A, Kreusch J, Stolz W, Argenziano G, Forsea AM, Marmol V D, Zalaudek I, Soyer HP, and Haenssle HA

Subjects
Cross-Sectional Studies, Dermatitis pathology, Dermatology education, Dermoscopy education, Europe, Female, Germany, Humans, Male, Melanoma pathology, Middle Aged, Nevus, Pigmented pathology, Skin Neoplasms pathology, Surveys and Questionnaires, Dermatology methods, Dermoscopy methods, Practice Patterns, Physicians'
Abstract

Background: Survey on the current status of dermoscopy in Germany., Methods: In the context of a pan-European internet-based study (n = 7,480) conducted by the International Dermoscopy Society, 880 German dermatologists were asked to answer questions with respect to their level of training as well as their use and perceived benefit of dermoscopy., Results: Seven hundred and sixty-two (86.6 %) participants practiced dermatology in a publicly funded health care setting; 98.4 % used a dermoscope in routine clinical practice. About 93 % (n = 814) stated to have had more than five years of experience in the use of dermoscopy. Dermoscopy was considered useful in the diagnosis of melanoma by 93.6 % (n = 824); for pigmented skin tumors, by 92.4 % (n = 813); in the follow-up of melanocytic lesions, by 88.6 % (n = 780); for non-pigmented lesions, by 71.4 % (n = 628), in the follow-up of non-melanocytic lesions, by 52.7 % (n = 464); and for inflammatory skin lesions, by 28.5 % (n = 251). Overall, 86.5 % (n = 761) of participants felt that - compared to naked-eye examination - dermoscopy increased the number of melanomas diagnosed; 77,7 % (n = 684) considered the number of unnecessary excisions of benign lesions to be decreased. Participants who personally felt that dermoscopy improved their ability to diagnose melanoma were significantly i) younger, ii) had been practicing dermatology for a shorter period of time, iii) were less commonly employed by an university-affiliated dermatology department, iv) were more frequently working in an office-based public health care setting, and v) had more frequently been trained in dermoscopy during their dermatology residency., Conclusions: The findings presented herein ought to be integrated into future residency and continuing medical education programs with the challenge to improve dermato-oncological care and to expand the diagnostic spectrum of dermoscopy to include inflammatory skin diseases., (© 2018 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.)

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results